The website of Pathology In Practice Magazine

SARS-CoV-2 antigen lateral-flow test detects Delta variant

A study has shown that the Avacta Group AffiDX antigen lateral-flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples, and outperformed two lateral-flow antigen tests that are commercially available in Europe.

Lateral-flow antigen tests are intended to provide a cost-effective and rapid means of identifying individuals with a high viral load that means they are more likely to infect others. The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral-flow test demonstrated 100% sensitivity for identifying infectious individuals with viral loads measured by PCR of Ct<27, which is considered infectious.

The SARS-CoV-2 virus, like most viruses, mutates over time to create different variants, and those that have a biological advantage will become a dominant strain. The Delta variant, first identified in India, has recently emerged, has greater infectivity, and may rapidly become a dominant strain worldwide.

The AffiDX SARS-CoV-2 antigen lateral-flow test has been evaluated with a small number of patient samples confirmed to be Delta variant positive and, for a Ct<29, the test was shown to correctly identify all the positive cases. In this study, two other commercially available lateral-flow tests were evaluated: One test detected half the positive cases and the other detected none.

The AffiDX SARS-CoV-2 antigen lateral-flow test is CE marked for professional use in the UK and EU. The company has recently appointed the first distributor for the test, Calibre Scientific, and is progressing multiple commercial opportunities with other distributors and professional end users in Europe and the UK.

www.avacta.com

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025